Kahn R. Wiedis

Kahn Wiedis is an associate in the firm’s Business Law department and a member of its Private Equity group. Kahn’s practice is devoted primarily to mergers and acquisitions, with an emphasis on representing private equity funds and their portfolio companies. He also represents public and private companies on transactions and other general corporate matters in a broad range of industries, including technology and software, healthcare, life sciences, consumer products, food and beverage, and financial services.

Kahn actively participates in various pro bono initiatives, including veteran advocacy and resolving tangled title real estate disputes in Philadelphia.

Prior to law school, Kahn served in the United States Marine Corps as a Forward Scout Observer in the artillery field.

• Represented TA Associates in its partial divestiture and recapitalization of AffiniPay, a legal practice management and integrated payments software provider 
• Represented Bregal Sagemount in its acquisition of Orange Logic, a developer of a digital asset management platform designed to maintain, store and share digital media libraries
• Represented Keensight Capital in its platform add-on acquisition of Contegix, a provider of Atlassian software consulting services 
• Represented InTandem Capital Partners in its acquisition of OrthoNebraska, a provider of musculoskeletal care
• Represented Tinicum in the divestiture of its portfolio company, PLX, a designer and manufacturer of high-precision optics for the defense and aerospace sector 
• Represented Primus Capital Partners in its acquisition of Bioprocure and Prendio, providers of a cloud-based eProcurement software built specifically for biotech companies
• Represented Leading2Lean, a portfolio company of M33 Growth, in its platform add-on acquisition of SwipeGuide, a Netherlands-based provider of front-line employee management and training technology solutions
• Represented Lock 8 Partners in its divestiture of its portfolio company, RelayHub, a provider of school-based Medicaid management and billing software
• Represented Celsius Therapeutics,  a clinical-stage biotechnology company developing novel medicines in inflammatory disease, in its sale to AbbVie, a global biopharmaceutical company 
• Represented GrowthZone, a portfolio company of Lead Edge Capital, in its platform add-on acquisition of Membersuite, a developer of cloud-based association management software
• Represented Apnimed in its formation of a U.S. joint venture with Shionogi, a leading global research-driven pharmaceutical company based in Japan
• Represented Thoma Bravo in its $1.8 billion acquisition of NextGen Healthcare, a leading provider of innovative healthcare technology solutions
• Represented global in-vitro diagnostics company in $400M acquisition of biotech developer of infectious disease tests for gastrointestinal and enteric diseases*
• Represented public multinational pharmaceutical company in $375M acquisition of injectable medicines supplier*
• Represented commercial-stage biotech company developing iPSC-derived cell therapies in immune-oncology in its $242M initial public offering*
• Represented medical marijuana dispensary in $80M acquisition by largest U.S. wholesaler of branded cannabis products*
• Represented clinical-stage biopharmaceutical company developing small molecule therapeutics for degenerative diseases in its $45M initial public offering*
• Represented public food conglomerate in $40M divestiture of baked goods portfolio company*
• Represented specialty materials company in divestiture of epoxides unit for $39M*

* Denotes experience prior to joining Goodwin.

Prior to joining Goodwin, Kahn worked as an associate at Troutman Pepper Hamilton Sanders LLP.

While in law school at Villanova University Charles Widger School of Law, Kahn worked as a student law counselor for the Clinic for Law and Entrepreneurship, where he advised a Philadelphia non-profit organization on organizational structure, compliance, and general business matters. He also served as the President of the Military and Veterans Law Society and the Chair of the Wills for Heroes program.

• Author, “High Time to Go Green: Environmental Impact of Marijuana Legalization,” Villanova Environmental Law Journal, 2020
• Co-Author, “Private Flood Insurance Rule Takes Effect July 1, Impacting Lenders and Borrowers,” Banking Law Journal, 2019
• Co-Author, “NJ Court Rules Incomplete Development Application Not Protected by Time of Application Rule,” Mid-Atlantic Real Estate Journal, 2018